Company Overview of Bioniz, LLC
Bioniz, LLC, a biotechnology/drug development company, develops small peptides and molecules for treatment of autoimmune diseases and some forms of cancer. It focuses on the development of a group of antagonist peptides that target the common-gamma receptor (?c); HAM/TSP (HTLV-I associated myelopathy/tropical spastic paraparesis), an orphan chronic progressive neurological disease that resembles multiple sclerosis in clinical manifestation; and autoimmune hepatitis, a chronic inflammatory disease of the liver. The company was founded in 2009 and is based in Irvine, California.
5 Mason Lane
Irvine, CA 92618
Founded in 2009
Key Executives for Bioniz, LLC
Bioniz, LLC Key Developments
Similar Private Companies By Industry
|Cellerant Therapeutics, Inc.||United States|
|Evivrus, Inc.||United States|
|Hybritech Incorporated||United States|
|Icogenex Corporation||United States|
|CytoGenix, Inc.||United States|
Recent Private Companies Transactions
October 15, 2014
To contact Bioniz, LLC, please visit www.bioniz.com. Company data is provided by Capital IQ. Please use this form to report any data issues.